ISRCTN29547753
Completed
Not Applicable
Cancer Research Campaign adjuvant breast trial for patients over the age of 50
Cancer Research UK (CRUK) (UK)0 sites0 target enrollmentJuly 1, 2001
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast
- Sponsor
- Cancer Research UK (CRUK) (UK)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged \>50 years and \<70 years (revised to \<80 years in February 1991\)
- •2\. Operable breast cancer (clinically T1, T2 or T3, N0 or N1, M0\)
- •3\. No evidence of metastases
- •4\. Normal renal and hepatic function, and full blood counts, including platelets
- •5\. Patients with bilateral tumours are not eligible
- •6\. No concomitant hormonal therapy or chemotherapy
- •7\. No previous malignancy, except basal or squamous cell carcinoma of the skin or in situ carcinoma of the cervix adequately cone biopsied
- •8\. Patients whose axillary nodes demonstrate deep fixity are not eligible
- •9\. Patients whose primary cancer is fixed to the underlying muscle or chest wall, or those with ulceration, skin infiltration, peau d'orange or satellite skin nodules are not eligible
- •10\. Fit to receive either treatment
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The NCRI adjuvant breast cancer (ABC) trialBreast cancerCancerISRCTN31514446Institute of Cancer Research (UK)6,000
Recruiting
Phase 2
Pre-operative phase II trial for breast cancer with nivolumab in combination with novel IO (BELLINI trial)NL-OMON54814ederlands Kanker Instituut90
Active, not recruiting
Phase 1
Pre-operative study for breast cancer with nivolumab in combination with other therapyMedDRA version: 21.1Level: LLTClassification code 10006188Term: Breast cancer female NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006194Term: Breast cancer NOS stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006195Term: Breast cancer NOS stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006196Term: Breast cancer NOS stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-004188-30-NLKI-AV90
Withdrawn
Not Applicable
A randomised controlled trial of breast cancer patients treated with chemotherapy in a hospital day unit or at home; an analysis of cost and patient reported outcomesBreast cancerCancer - BreastPublic Health - Health service researchACTRN12615000197538A/Prof Suzanne Robinson130
Completed
Not Applicable
Cancer Research Campaign trial for the treatment of women with early breast cancer: the role of local prophylactic radiotherapyBreastCancerISRCTN65764657Cancer Research UK (CRUK) (UK)